文献速递头颈外科

弥散加权MRI诊断放化疗后头颈部鳞状细胞癌持续或复发的系统评价与Meta分析

Diffusion-Weighted MRI for Recurrent/Persistent Head and Neck Squamous-Cell Carcinoma After Radiotherapy: Systematic Review and Meta-Analysis.
PubMed 文献 · Otolaryngol Head Neck Surg · 2024-08-18

该系统评价与Meta分析纳入10项研究共618例患者,评估弥散加权MRI(DWI-MRI)诊断原发放化疗后头颈部鳞状细胞癌(HNSCC)持续或复发的准确性。原发灶定性分析汇总敏感度0.96、特异度0.81;颈淋巴结定性分析汇总敏感度0.87、特异度0.84。作者认为DWI-MRI诊断准确性高,怀疑持续或复发HNSCC时应考虑使用,定性与定量评估无显著差异。

要点

  • 原发灶定性分析汇总敏感度0.96(95%CI 0.89-1.00),特异度0.81(95%CI 0.54-0.98)。
  • 颈淋巴结定性分析汇总敏感度0.87(95%CI 0.75-0.95),特异度0.84(95%CI 0.74-0.93)。
  • 定性与定量评估之间未发现显著差异。

核心结论

  • DWI-MRI诊断准确性高,原发放化疗后怀疑HNSCC持续或复发时应考虑使用。
  • 定性与定量影像评估之间未发现显著差异。

研究设计与样本

  • 系统评价与Meta分析,检索Scopus、PubMed/MEDLINE和Cochrane Library数据库截至2023年4月18日的文献。
  • 纳入10项研究共618例患者计算诊断准确性参数。
  • 由2名研究者独立检索,采用QUADAS-2问卷评估纳入研究的方法学质量。

主要发现

  • 原发灶定性分析汇总敏感度0.96(95%CI 0.89-1.00),特异度0.81(95%CI 0.54-0.98)。
  • 原发灶定量分析汇总敏感度0.79(95%CI 0.66-0.89),特异度0.88(95%CI 0.77-0.96)。
  • 颈淋巴结定性分析汇总敏感度0.87(95%CI 0.75-0.95),特异度0.84(95%CI 0.74-0.93)。
  • 颈淋巴结定量分析汇总敏感度0.79(95%CI 0.60-0.94),特异度0.90(95%CI 0.82-0.97)。

临床怎么用

  • 作者认为,原发放化疗后怀疑HNSCC持续或复发时应考虑DWI-MRI。
  • 定性与定量影像评估之间未发现显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the accuracy of diffusion-weighted magnetic resonance imaging (DWI-MRI) in diagnosing persistent/recurrent head and neck squamous cell carcinomas (HNSCCs) after primary chemoradiotherapy (CRT). DATA SOURCES: Scopus, PubMed/MEDLINE, and Cochrane Library databases were searched for relevant publications until April 18, 2023. REVIEW METHODS: A systematic review and meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses of Diagnostic Test Accuracy statement. The search was conducted independently by 2 investigators. Methodological quality of included studies was assessed using the Quality Assessment of Diagnostic Studies-2 questionnaire. Extracted data were used to calculate the pooled DWI-MRI sensitivity, specificity, diagnostic odds ratio, and positive and negative likelihood ratio. RESULTS: A total of 618 patients from 10 studies were included for calculation of diagnostic accuracy parameters. At the level of the primary tumor, the pooled sensitivity and specificity were, respectively, 0.96 (95% confidence interval [CI]: 0.89-1.00) and 0.81 (95% CI: 0.54-0.98) in the case of qualitative analysis, and, respectively, 0.79 (95% CI: 0.66-0.89) and 0.88 (95% CI: 0.77-0.96) for quantitative analysis. At the level of the neck, the pooled sensitivity and specificity were, respectively, 0.87 (95% CI: 0.75-0.95) and 0.84 (95% CI: 0.74-0.93) when images were analyzed qualitatively, and 0.79 (95% CI: 0.60-0.94) and 0.90 (95% CI: 0.82-0.97) when analyzed quantitatively. CONCLUSION: DWI-MRI showed high diagnostic accuracy and should be considered if persistent/recurrent HNSCCs is suspected after primary CRT. No significant differences were found between qualitative and quantitative imaging assessment.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Canali L, Costantino A, Mari G, et al. Diffusion-Weighted MRI for Recurrent/Persistent Head and Neck Squamous-Cell Carcinoma After Radiotherapy: Systematic Review and Meta-Analysis. Otolaryngol Head Neck Surg. 2024. PMID: 39154260. doi:10.1002/ohn.949

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。